Сравнение методов

	Дифференциальный метаболомный анализ	Анализ метаболомики с использованием машинного обучения
Область	Биоинформатика	Биоинформатика
Семейство	Process / pipeline	Process / pipeline
Год появления	2000s–2010s (field formalised alongside mass spectrometry advances)	2000s–2010s (rapid adoption 2015–present)
Автор метода	Developed through convergent contributions by multiple groups; XCMS (Siuzdak lab, 2006) and MetaboAnalyst (Wishart lab, 2009–2015) are foundational computational implementations	Convergent development; foundational reviews by Liebal et al. (2020) and earlier multivariate metabolomics work by Trygg, Holmes, and Nicholson
Тип	Quantitative comparative omics pipeline	Integrative analytical pipeline
Основополагающий источник	Xia, J., Sinelnikov, I. V., Han, B., & Wishart, D. S. (2015). MetaboAnalyst 3.0 — making metabolomics more meaningful. Nucleic Acids Research, 43(W1), W251–W257.	Liebal, U. W., Phan, A. N. T., Sudhakar, M., Raman, K., & Blank, L. M. (2020). Machine learning applications for mass spectrometry-based metabolomics. Metabolites, 10(6), 243.
Другие названия	comparative metabolomics, differential metabolite profiling, metabolomic differential analysis, DMA	ML-metabolomics, chemoinformatics ML, metabolite profiling with machine learning, ML-driven metabolic profiling
Связанные	6	1
Сводка	Differential metabolomics analysis is a computational pipeline that identifies metabolites whose abundance levels differ significantly between two or more biological conditions — such as disease versus control, treated versus untreated, or different developmental stages. By integrating mass spectrometry or NMR data with statistical modelling and pathway databases, it translates raw spectral measurements into biologically interpretable lists of perturbed metabolic features and the pathways they implicate.	Machine learning-assisted metabolomics analysis is an integrative bioinformatics pipeline that couples untargeted or targeted metabolite profiling — via mass spectrometry or NMR — with supervised and unsupervised ML algorithms to discover biomarkers, classify phenotypes, and model metabolic states. By handling the extreme dimensionality and collinearity inherent in metabolomics datasets (hundreds to thousands of features, tens to hundreds of samples), ML methods such as random forests, support vector machines, and neural networks extract biologically interpretable patterns that classical univariate statistics routinely miss.